Trial Profile
Pharmacokinetics and Pharmacodynamics of apixaban in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 27 May 2015 New trial record